CMD Insider Trading Activity and SEC Form 4 Filings
CMD insider trading summary
No open-market insider purchases or sales of Cantel Medical Corp (CMD) have been reported on SEC Form 4 in the past 12 months.
Latest CMD insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 5, 2021 | Ann E Berman | Director | Sell | $453K (5,500 @ $82.41) |
| Jul 13, 2020 | Brian Capone | SVP and Princ. Accounting Ofr | Sell | $13K (300 @ $44.13) |
| Mar 26, 2020 | Anthony B Evnin | Director | Buy | $48K (1,200 @ $40.37) |
| Mar 26, 2020 | Anthony B Evnin | Director | Buy | $49K (1,300 @ $37.40) |
| Mar 23, 2020 | George L Fotiades | President and CEO | Buy | $216K (10,000 @ $21.55) |
| Mar 16, 2020 | George L Fotiades | President and CEO | Buy | $274K (8,000 @ $34.22) |
| Mar 6, 2020 | George L Fotiades | President and CEO | Buy | $265K (5,000 @ $52.94) |
| Jan 23, 2020 | Jeffrey Z Mann | SVP, General Counsel | Buy | $50K (750 @ $67.30) |
| Jan 17, 2020 | Mark N. Diker | Director | Buy | $62K (1,000 @ $62.43) |
| Jan 17, 2020 | Mark N. Diker | Director | Buy | $62K (1,000 @ $62.42) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.